Latest stories on NRIX
Nurix Therapeutics, Inc. (NRIX) files 8-K
SEC 8-K50 · neutralgeneral
Nurix Therapeutics GAAP EPS of -$0.81 misses by $0.08, revenue of $9.04M misses by $6.25M
Seeking Alpha34 · bearishearnings
Nurix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update | NRIX Stock News
StockTitan73 · bullishearnings
Nurix Therapeutics, Inc. (NRIX) Price Target Raised to $33 on Roche Partnership Value
Yahoo Top61 · neutralanalyst
Nurix (NRIX) Climbs to 52-Week High — This Deal May Hold the Answer
Yahoo Top73 · bullishproduct/pr
Truist is Bullish on Nurix Therapeutics, Inc. (NRIX)
Yahoo Top61 · neutralanalyst
Nurix Therapeutics Deal With Roche Is Worth Betting On
Seeking Alpha67 · bullishproduct/pr
Nurix Highlights Promising Phase 1b Data for Bexobrutideg
TipRanks67 · bullishproduct/pr
Nurix Therapeutics, Inc. (NRIX) files 8-K
SEC 8-K50 · neutralgeneral
Nurix Therapeutics: 'Strong Buy' Due To Roche Deal And Bexobrutideg Expansions
Seeking Alpha76 · bullishanalyst
Roche Licenses Nurix Therapeutics Blood-Cancer Drug for Up to $2.3 Billion — Update
Morningstar73 · bullishm&a
Roche enters cancer drug deal worth up to $2.3 billion with Nurix Therapeutics
Reuters73 · bullishm&a
This Biotech Stock Is Up 11% on $2.3 Billion Roche Deal for Blood Cancer Drug
Barron's73 · bullishm&a
Nurix and Roche forge global BTK degrader alliance
TipRanks73 · bullishm&a
Nurix Therapeutics Shares Surge Premarket on Roche Deal
Morningstar73 · bullishm&a
NRIX Stock Surges Nearly 70% Premarket Today – Roche And Nurix’s Blood Cancer Drug Collaboration Can Tap A $41B Market
Stocktwits News73 · bullishproduct/pr
Nurix Therapeutics Stock (NRIX) Soars 40% After $2.3B Blood Cancer Deal with Roche
TipRanks86 · bullishm&a
Nurix Therapeutics, Inc. (NRIX) files 8-K
SEC 8-K50 · neutralgeneral
Biggest stock movers Monday: NRIX, HON, and more
Seeking Alpha50 · neutralgeneral
Nurix surges 43% on up to $3B cancer drug deal with Roche
Seeking Alpha78 · bullishm&a